Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 64

Results For "NFI"

1028 News Found

Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies
News | June 10, 2022

Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies

During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.


National Ayurveda Research Institute for Panchakarma bags NABL Accreditation
News | June 09, 2022

National Ayurveda Research Institute for Panchakarma bags NABL Accreditation

A big boost to healthcare efforts of Ayush through NARIP, CCRAS


CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox
Diagnostic Center | June 08, 2022

CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox

CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit


FDA publishes ANP’s polymeric drug excipient DMF
Drug Approval | June 06, 2022

FDA publishes ANP’s polymeric drug excipient DMF

The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.


APhA appoints Ilisa Bernstein Interim CEO
People | June 06, 2022

APhA appoints Ilisa Bernstein Interim CEO

Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA


Innate Pharma announces IPH5201 phase 2 study in lung cancer
News | June 04, 2022

Innate Pharma announces IPH5201 phase 2 study in lung cancer

Innate to receive $5M milestone payment from AstraZeneca


Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing
People | June 03, 2022

Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing

Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead


GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion
News | June 03, 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion

GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones


GSK to form consumer healthcare business ‘Haleon’
News | June 03, 2022

GSK to form consumer healthcare business ‘Haleon’

The proposed demerger is the most significant corporate change for GSK in the last 20 years


PAYBACK India announces a strategic partnership with Apollo Pharmacy
News | June 01, 2022

PAYBACK India announces a strategic partnership with Apollo Pharmacy

PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India